Search Results - "DANIELS, CRAIG E"

Refine Results
  1. 1

    Idiopathic Pulmonary Fibrosis: Evolving Concepts by Ryu, Jay H., MD, Moua, Teng, MD, Daniels, Craig E., MD, Hartman, Thomas E., MD, Yi, Eunhee S., MD, Utz, James P., MD, Limper, Andrew H., MD

    Published in Mayo Clinic proceedings (01-08-2014)
    “…Abstract Idiopathic pulmonary fibrosis (IPF) occurs predominantly in middle-aged and older adults and accounts for 20% to 30% of interstitial lung diseases. It…”
    Get full text
    Journal Article
  2. 2

    Pleural Fluid Characteristics of Chylothorax by Maldonado, Fabien, MD, Hawkins, Finn J., MBBCh, Daniels, Craig E., MD, Doerr, Clinton H., MD, Decker, Paul A., MS, Ryu, Jay H., MD

    Published in Mayo Clinic proceedings (01-02-2009)
    “…OBJECTIVE To determine the biochemical parameters of chylous pleural fluids and better inform current clinical practice in the diagnosis of chylothorax…”
    Get full text
    Journal Article
  3. 3

    Frequency and Implication of Autoimmune Serologies in Idiopathic Pulmonary Fibrosis by Moua, Teng, MD, Maldonado, Fabien, MD, Decker, Paul A., MS, Daniels, Craig E., MD, Ryu, Jay H., MD

    Published in Mayo Clinic proceedings (01-03-2014)
    “…Abstract Objective To assess the frequency and clinical implications of positive autoimmune serologies in patients with biopsy-confirmed idiopathic pulmonary…”
    Get full text
    Journal Article
  4. 4

    Ventilator settings and outcome of respiratory failure in chronic interstitial lung disease by Fernández-Pérez, Evans R, Yilmaz, Murat, Jenad, Hussam, Daniels, Craig E, Ryu, Jay H, Hubmayr, Rolf D, Gajic, Ognjen

    Published in Chest (01-05-2008)
    “…While patients with interstitial lung disease (ILD) may be particularly susceptible to ventilator-induced lung injury, ventilator strategies have not been…”
    Get more information
    Journal Article
  5. 5

    The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules by Daniels, Craig E, Lowe, Val J, Aubry, Marie-Christine, Allen, Mark S, Jett, James R

    Published in Chest (01-01-2007)
    “…Fluorodeoxyglucose positron emission tomography (FDG-PET) is sensitive for detection of neoplastic solitary pulmonary nodules but may have decreased…”
    Get more information
    Journal Article
  6. 6
  7. 7

    Diagnosis of Interstitial Lung Diseases by Ryu, Jay H., MD, Daniels, Craig E., MD, Hartman, Thomas E., MD, Yi, Eunhee S., MD

    Published in Mayo Clinic proceedings (01-08-2007)
    “…Interstitial lung diseases (ILDs), a broad heterogeneous group of parenchymal lung disorders, can be classified into those with known and unknown causes. The…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    B-type natriuretic peptide in the assessment of acute lung injury and cardiogenic pulmonary edema by Rana, Rimki, Vlahakis, Nicholas E, Daniels, Craig E, Jaffe, Allan S, Klee, George G, Hubmayr, Rolf D, Gajic, Ognjen

    Published in Critical care medicine (01-07-2006)
    “…OBJECTIVE:The role of plasma B-type natriuretic peptide (BNP) in critically ill patients with acute pulmonary edema is controversial. We postulated that a low…”
    Get full text
    Journal Article
  12. 12

    Pulmonary embolus diagnosed by endobronchial ultrasound by Segraves, Justin M, Daniels, Craig E

    Published in Respiratory medicine case reports (01-01-2015)
    “…Abstract Endobronchial ultrasound (EBUS) imaging is commonly used to evaluate and aid in biopsy of mediastinal lymph nodes. Pulmonary arteries are readily…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Patients With Fibrotic Interstitial Lung Disease Hospitalized for Acute Respiratory Worsening: A Large Cohort Analysis by Moua, Teng, Westerly, Blair D, Dulohery, Megan M, Daniels, Craig E, Ryu, Jay H, Lim, Kaiser G

    Published in Chest (01-05-2016)
    “…Acute respiratory worsening (ARW) requiring hospitalization in patients with fibrotic interstitial lung disease (f-ILD) is common. Little is known about the…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Imatinib Treatment for Idiopathic Pulmonary Fibrosis: Randomized Placebo-controlled Trial Results by DANIELS, Craig E, LASKY, Joseph A, LIMPER, Andrew H, MIERAS, Kathleen, GABOR, Edith, SCHROEDER, Darrell R

    “…Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with no known efficacious therapy. Imatinib is a tyrosine kinase inhibitor with potential…”
    Get full text
    Journal Article
  18. 18

    Making paracentesis safer: a proposal for the use of bedside abdominal and vascular ultrasonography to prevent a fatal complication by Sekiguchi, Hiroshi, Suzuki, Jun, Daniels, Craig E

    Published in Chest (01-04-2013)
    “…Paracentesis has been considered a relatively safe procedure; however, hemorrhagic complications do occur and can be fatal, especially in the context of…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study by Fernández Pérez, Evans R, Daniels, Craig E, Schroeder, Darrell R, St Sauver, Jennifer, Hartman, Thomas E, Bartholmai, Brian J, Yi, Eunhee S, Ryu, Jay H

    Published in Chest (01-01-2010)
    “…Limited data exist regarding the population-based epidemiology of idiopathic pulmonary fibrosis (IPF). The objective of the study was to describe the trends in…”
    Get more information
    Journal Article